CLINICAL_TRIALS
trial_result
· 2019-12-04
Clinical Trial Update: Enhancement of in-Vitro GC Function in Patients With COPD [Phase 2]
Summary
Phase 2 trial evaluating enhancement of in-vitro glucocorticoid function in patients with COPD has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2019-12-04